Tarsus Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87650L1035

SecurityTARS / Tarsus Pharmaceuticals, Inc.
InsiderWilliam J Phd Link
This page shows the track record and history of LINK WILLIAM J PHD insider trades in Tarsus Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by William J Phd Link in TARS / Tarsus Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by William J Phd Link in TARS / Tarsus Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-08 27,116 57.0000 27,116 57.0000 1,545,612 4 49.3300 -207,980 -13.46
2024-08-12 29,979 26.0100 29,979 26.0100 779,754
2024-08-12 5,021 26.5300 5,021 26.5300 133,207

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-10 2025-09-08 4 LINK WILLIAM J PHD TARS Common Stock S - Sale D 57.0000 -27,116 -1,546 143,332
2025-06-16 2025-06-13 4 LINK WILLIAM J PHD TARS Common Stock M - Exercise D 3,350 170,448
2024-08-14 2024-08-12 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock S - Sale I 26.5300 -5,021 -133 0
2024-08-14 2024-08-12 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock S - Sale I 26.0100 -29,979 -780 5,021
2024-08-14 2024-08-12 4 LINK WILLIAM J PHD TARS Common Stock J - Other D 27,116 167,098
2024-08-14 2024-08-12 4 LINK WILLIAM J PHD By Link Family Enterprise, LP TARS Common Stock J - Other I 10,446 10,446
2024-08-14 2024-08-12 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I -74,892 35,000
2024-06-25 2024-06-24 4 LINK WILLIAM J PHD TARS Common Stock M - Exercise D 3,350 139,982
2023-06-21 2023-06-16 4 LINK WILLIAM J PHD TARS Common Stock M - Exercise D 2,000 136,632
2023-05-15 2023-05-11 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I 41,219 109,892
2023-05-15 2023-05-11 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock J - Other I -215,576 0
2023-03-17 2023-03-15 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I 52,194 68,673
2023-03-17 2023-03-15 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock J - Other I -215,575 215,576
2022-11-14 2022-11-10 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I 8,382 16,479
2022-11-14 2022-11-10 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock J - Other I -215,575 431,151
2022-08-17 2022-08-15 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I 3,749 8,097
2022-08-17 2022-08-15 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock J - Other I -215,575 646,726
2021-11-16 2021-11-11 4 LINK WILLIAM J PHD By Flying L Partners XI, LLC TARS Common Stock J - Other I 4,348 4,348
2021-11-16 2021-11-11 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock J - Other I -250,000 862,301
2021-06-17 2021-06-15 4 LINK WILLIAM J PHD TARS Stock Option (right to buy) A - Award D 35.26 10,000 10,000
2021-06-17 2021-06-15 4 LINK WILLIAM J PHD TARS Stock Option (right to buy) A - Award D 35.26 10,000 10,000
2020-10-20 2020-10-20 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Series B Preferred Stock C - Conversion I -1,112,301 0
2020-10-20 2020-10-20 4 LINK WILLIAM J PHD By Flying L Investments XI, LLC TARS Common Stock C - Conversion I 1,112,301 1,112,301
2020-10-15 3 LINK WILLIAM J PHD TARS Common Stock D 134,632
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)